ArticleJournal of ophthalmic inflammation and infection2023

Risk of failing both methotrexate and mycophenolate mofetil from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) uveitis trial.

Amit K Reddy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.